Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes
Authors
Keywords
-
Journal
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 172, Issue 3, Pages 375-382
Publisher
Wiley
Online
2013-01-18
DOI
10.1111/cei.12068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Histone Deacetylase 3 Protects Beta Cells from Cytokine-Induced Apoptosis
- (2012) Danny Hung-Chieh Chou et al. CHEMISTRY & BIOLOGY
- Targeting Regulatory T Cells in the Treatment of Type 1 Diabetes Mellitus
- (2012) S.M. Cabrera et al. CURRENT MOLECULAR MEDICINE
- Islet -Cell Endoplasmic Reticulum Stress Precedes the Onset of Type 1 Diabetes in the Nonobese Diabetic Mouse Model
- (2012) S. A. Tersey et al. DIABETES
- Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children
- (2012) M. Lundh et al. DIABETOLOGIA
- The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice
- (2012) Jacob Jelsing et al. JOURNAL OF ENDOCRINOLOGY
- How Does Type 1 Diabetes Develop?: The Notion of Homicide or -Cell Suicide Revisited
- (2011) M. A. Atkinson et al. DIABETES
- Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trial
- (2011) S. L. Ellis et al. DIABETIC MEDICINE
- Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice
- (2011) Tejas Patel et al. IMMUNOLOGY AND CELL BIOLOGY
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
- (2011) Diane K Wherrett et al. LANCET
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Unknown
- (2011) Eli Lewis et al. MOLECULAR MEDICINE
- Rapamycin prevents the onset of insulin-dependent diabetes mellitus (IDDM) in NOD mice
- (2010) W. L. BAEDER et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor
- (2010) Lei Tian et al. ENDOCRINOLOGY
- Inhibition of Deoxyhypusine Synthase Enhances Islet β Cell Function and Survival in the Setting of Endoplasmic Reticulum Stress and Type 2 Diabetes
- (2010) Reiesha D. Robbins et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peroxisome Proliferator-Activated Receptor Activation Restores Islet Function in Diabetic Mice through Reduction of Endoplasmic Reticulum Stress and Maintenance of Euchromatin Structure
- (2009) C. Evans-Molina et al. MOLECULAR AND CELLULAR BIOLOGY
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice
- (2008) Christopher M. Reilly et al. JOURNAL OF AUTOIMMUNITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now